IMO, public information is available to anyone. We have equal access to such.
Following your post, both dilution and cash burns are downside elements, Feldman has fail to provide any information over these key issues, despite the many public shows on media selling his (empty) promises.
I seriously doubt your research methodology and information sources.
Given the great disparity between what CGB promises and what shareholders experience, the growing concerns are commonly shared among majority shareholders.
Without any answer to the fundamental queries, your confidence over CGB is doubtful too.
- Forums
- ASX - By Stock
- CGB
- Ann: CANNTAB PRODUCTS TO LAUNCH IN AUSTRALIA
Ann: CANNTAB PRODUCTS TO LAUNCH IN AUSTRALIA, page-112
-
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online